Multicenter Application Verification and Effect Evaluation of Artificial Intelligence-Based Snake Species Identification System in the Diagnosis and Treatment of Snakebites

NCT07658885 · tracked via the Priya Life Science China tracker

Sponsor

Second Affiliated Hospital, Zhejiang University, School of Medicine

Phase

Observational

Started

2026-06-20

Last updated

2026-06-22

Condition(s) studied

Snake Bite

Investigational drug(s) / intervention(s)

SSRS system-assisted snake species identification

SSRS system-assisted snake species identification: Without interfering with clinical treatment, simultaneously record the physician's assessment and the identification results from the SSRS system.

Study summary

This multicenter prospective observational study aims to develop and validate a deep learning-based artificial intelligence snake species identification system, and evaluate its clinical application efficacy in real-world emergency snakebite treatment scenarios. The primary research question it seeks to answer is:

In real clinical settings in Zhejiang Province, can the artificial intelligence snake species identification system accurately identify common indigenous snake species causing bites, and improve the accuracy and diagnostic efficiency of snake species judgment for physicians at different levels of medical institutions? This study will be conducted simultaneously in 10 medical institutions in Zhejiang Province. investigators will prospectively enroll patients with snakebite who present to the hospital between June 2026 and December 2026 and can provide photographs of the offending snakes. The snake species identification results of both attending physicians and the artificial intelligence system will be recorded synchronously, and the patients' clinical treatment and prognosis data will be collected. All patients will be followed up until 30 days after discharge.

Eligibility

Sex

ALL

Min age

18 Years

Max age

80 Years

Healthy volunteers

Inclusion Criteria: 1. Adult patients aged ≥18 years, regardless of gender 2. Definite history of snake bite, with time from bite occurrence to first medical visit ≤24 hours 3. The patient or eyewitness can provide digital images of the biting snake (taken by mobile phone, camera, etc.) 4. Voluntarily sign the written informed consent form; for patients with impaired consciousness who cannot sign independently, their legal representative shall sign on their behalf, and a secondary confirmation shall be obtained after the patient regains consciousness 5. Able to cooperate in completing follow-up assessments at discharge and 30 days after injury Exclusion Criteria: * 1\. Unable to provide snake images, or images are severely blurred resulting in complete loss of key identification features 2. Snake species cannot be confirmed by the gold standard (no eyewitnesses, no typical clinical manifestations, cannot be clarified by expert panel consultation) 3. Medical visit exceeds 24 hours and the exact bite time and initial clinical manifestations cannot be determined 4. Complicated with end-stage malignant tumors, severe liver and kidney failure, or other underlying diseases that may significantly affect prognosis judgment 5. Refuse to sign the informed consent form or cannot cooperate in completing follow-up 6. Simultaneously participating in other clinical studies that may affect the results of this study

Primary outcome measure(s)

Snake species identification (64-class classification) and venomous/non-venomous snake discrimination (binary classification) — From enrollment to the end of treatment at 30 days

Trial sites (1)

Facility	City	Region	Status
Second Affiliated Hospital, Zhejiang University School of Medicine	Hangzhou	Zhejiang

More Second Affiliated Hospital, Zhejiang University, School of Medicine trials in China

Microneedle Intra-Arterial Injection for Retinal Artery Occlusion Recruiting

Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease Recruiting

Multicenter Study on the Use of Intraoperative OCT in the Diagnosis and Management of Lens Diseases Active, not recruiting

China Longitudinal Aging and Cognitive Impairment Study Recruiting

Effect of Incentive Integrated E-IBD Chronic Disease Management Model on the Quality of Life in IBD Patients Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07658885 on ClinicalTrials.gov ↗ ← All trials in China